Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-04-26, Stock:NVS, The news for the past five days is as follows:
2018-04-19: NEWS1: Novartis AG (ADR) Stock Drops on Q1 Earnings Miss.NEWS2: Novartis AG (ADR) Stock Drops on Q1 Earnings Miss.NEWS3: Novartis AG (NVS) Q1 2018 Earnings Conference Call Transcript.NEWS4: Novartis AG (NVS) Q1 2018 Earnings Conference Call Transcript.NEWS5: Novartis Stock Dips After Cosentyx Sales, Sandoz Generics Disappoint.NEWS6: Health Care Sector Update for 04/19/2018: AGN,SHPG,GILD,NVS,DHR.NEWS7: Health Care Sector Update for 04/19/2018: AGN,SHPG,GILD,NVS,DHR.NEWS8: Novartis AG (ADR) Stock Drops on Q1 Earnings Miss.NEWS9: Health Care Sector Update for 04/19/2018: GILD,NVS,DHR.NEWS10: Health Care Sector Update for 04/19/2018: GILD,NVS,DHR.NEWS11: Novartis AG (NVS) Q1 2018 Earnings Conference Call Transcript.NEWS12: Novartis (NVS) Beats Earnings and Revenue Estimates in Q1.NEWS13: Health Care Sector Update for 04/19/2018: NVS, DHR, ALGN, GILD, 4503.T.NEWS14: Health Care Sector Update for 04/19/2018: NVS, DHR, ALGN, GILD, 4503.T.NEWS15: SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of AveXis, Inc. - AVXS.NEWS16: Sanofi to Divest European Generic Unit, Streamline Business.NEWS17: The Swiss Stock Market Finished Nearly Flat After Paring Early Gains.NEWS18: The Swiss Stock Market Finished Nearly Flat After Paring Early Gains.NEWS19: Novartis CEO feels heat on U.S. generics, Cosentyx drop.NEWS20: European Markets Finished Little Changed In Directionless Trade.NEWS21: European Markets Finished Little Changed In Directionless Trade.NEWS22: Vyxeos Could Be Jazz Pharmaceuticals’ Long-Term Growth Driver.NEWS23: Novartis Earnings Top, But Key Drug, Generics Sales Disappoint.NEWS24: Earnings Reaction History: Novartis AG, 55.6% Follow-Through Indicator, 2.2% Sensitive.NEWS25: Earnings Reaction History: Novartis AG, 55.6% Follow-Through Indicator, 2.2% Sensitive.NEWS26: Novartis: 1Q Earnings Snapshot.NEWS27: [$$] Cancer and heart drugs boost Novartis sales .NEWS28: Novartis 1Q profit jumps 12 percent as heart drug sales soar.NEWS29: Novartis 1Q profit jumps 12 percent as heart drug sales soar.NEWS30: [$$] Novartis Buoyed by Heart Drug.NEWS31: [$$] Greek parliament ends probe into bribery allegations.NEWS32: European Shares Hold Steady Amid Earnings Deluge.NEWS33: European Shares Hold Steady Amid Earnings Deluge.NEWS34: Novartis Q1 Profit Climbs, Misses Estimates; Backs FY18 View - Quick Facts.NEWS35: Novartis Q1 Profit Climbs, Misses Estimates; Backs FY18 View - Quick Facts.NEWS36: Roche Hemophilia Drug Gets Breakthrough Therapy Designation.NEWS37: Roche Hemophilia Drug Gets Breakthrough Therapy Designation.
2018-04-20: NEWS1: What's in the Cards for Glaxo (GSK) This Earnings Season?.NEWS2: What's in the Cards for Glaxo (GSK) This Earnings Season?.NEWS3: Shire (SHPG) Turns Down Takeda's Third Buyout Proposition.NEWS4: Shire (SHPG) Turns Down Takeda's Third Buyout Proposition.NEWS5: Pharma Stock Roundup: NVS, JNJ Q1 Sales & Earnings Top, MRK & BMY Active at AACR.NEWS6: Pharma Stock Roundup: NVS, JNJ Q1 Sales & Earnings Top, MRK & BMY Active at AACR.NEWS7: Novartis (NVS) Reports Encouraging Data on MS Candidate.NEWS8: Novartis (NVS) Reports Encouraging Data on MS Candidate.NEWS9: J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit?.NEWS10: J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit?.NEWS11: Shire (SHPG) Turns Down Takeda&apos;s Third Buyout Proposition.NEWS12: What&apos;s in the Cards for Glaxo (GSK) This Earnings Season?.NEWS13: Novartis (NVS) Reports Encouraging Data on MS Candidate.NEWS14: Pharma Stock Roundup: NVS, JNJ Q1 Sales & Earnings Top, MRK & BMY Active at AACR.NEWS15: J&J, Novartis&apos; Q1 Earnings Impress: Will Others Follow Suit?.NEWS16: The Swiss Stock Market Pulled Back As Novartis Weakens Further.NEWS17: The Swiss Stock Market Pulled Back As Novartis Weakens Further.NEWS18: Novartis: EXPAND Study Solidifies Clinical Evidence For Siponimod - Quick Facts.NEWS19: Novartis: EXPAND Study Solidifies Clinical Evidence For Siponimod - Quick Facts.
2018-04-23: NEWS1: Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN.NEWS2: Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN.NEWS3: Roche (RHHBY) Presents Encouraging Data on MS Drug Ocrevus.NEWS4: Roche (RHHBY) Presents Encouraging Data on MS Drug Ocrevus.NEWS5: The Swiss Stock Market Finished Nearly Unchanged.NEWS6: The Swiss Stock Market Finished Nearly Unchanged.
2018-04-24: NEWS1: Top Research Reports for Johnson & Johnson, Honeywell & Morgan Stanley.NEWS2: Top Research Reports for Johnson & Johnson, Honeywell & Morgan Stanley.NEWS3: Top Research Reports for Johnson & Johnson, Honeywell & Morgan Stanley.NEWS4: Centene (CNC) Q1 Earnings & Revenues Top, '18 View Lowered.NEWS5: Centene (CNC) Q1 Earnings & Revenues Top, '18 View Lowered.NEWS6: Notable ETF Inflow Detected - VXUS, NSRGY, TSM, NVS.NEWS7: Notable ETF Inflow Detected - VXUS, NSRGY, TSM, NVS.NEWS8: Is Bellicum Pharmaceuticals, Inc. a Buy?.NEWS9: Is Bellicum Pharmaceuticals, Inc. a Buy?.NEWS10: This Small Biotech Is Building on a Surprising Success.NEWS11: This Small Biotech Is Building on a Surprising Success.NEWS12: The Swiss Stock Market.NEWS13: The Swiss Stock Market.NEWS14: Is Biopharma Investing Too Much In Cancer R&D?.
2018-04-25: NEWS1: 5 Biotech ETFs for Outsized Gains.NEWS2: Analysts’ Views on Sanofi, Pre-1Q18 Earnings Release.NEWS3: Amgen (AMGN) Earnings Beat Estimates in Q1, Revenues Up Y/Y.NEWS4: Amgen (AMGN) Earnings Beat Estimates in Q1, Revenues Up Y/Y.NEWS5: Novartis Delivered Strong Performance in 1Q18.NEWS6: Anthem (ANTM) Beats on Q1 Earnings, Raises '18 Guidance.NEWS7: Anthem (ANTM) Beats on Q1 Earnings, Raises '18 Guidance.NEWS8: Drug Stock Q1 Earnings Due on Apr 26: ABBV, ALXN, BMY & VRTX.NEWS9: Drug Stock Q1 Earnings Due on Apr 26: ABBV, ALXN, BMY & VRTX.NEWS10: GlaxoSmithKline: Operating Revenues Up in 1Q18 Earnings.NEWS11: Novartis Launches FocalView to Modernize Clinical Trials.NEWS12: Amgen’s Earnings Grow 12% Year-Over-Year in 1Q18.NEWS13: The Zacks Analyst Blog Highlights: Johnson & Johnson, Honeywell, Morgan Stanley, Novartis and eBay.NEWS14: The Zacks Analyst Blog Highlights: Johnson & Johnson, Honeywell, Morgan Stanley, Novartis and eBay.NEWS15: Gilead Sciences has a Strong Oncology Research Program.NEWS16: The Swiss Stock Market Pulled Back With The Rest Of Europe.NEWS17: The Swiss Stock Market Pulled Back With The Rest Of Europe.NEWS18: The Zacks Analyst Blog Highlights: Johnson & Johnson, Honeywell, Morgan Stanley, Novartis and eBay.NEWS19: Glaxo (GSK) Misses on both Earnings and Revenue in Q1.NEWS20: Novartis' digital drive continues with eye-disease app.NEWS21: Novartis' digital drive continues with eye-disease app.NEWS22: [$$] How Long Till the Final World Malaria Day?.

Answer: Rise